Small cell architecture - A histological equivalent of EGFR amplification in glioblastoma multiforme?

Peter C. Burger, Dennis Keith Pearl, Kenneth Aldape, Allan J. Yates, Bernd W. Scheithauer, Sandra M. Passe, Robert B. Jenkins, C. David James

Research output: Contribution to journalArticle

105 Citations (Scopus)

Abstract

Although there is much written about the molecular definitions of "primary" glioblastomas (GBM), there is little known about the histological features of this predominant subtype. We hypothesized that the "small cell architecture" would represent a histological feature of most primary GBMs. This was tested by comparing the presence of the small cell phenotype with the presence or absence of amplification of the epidermal growth factor receptor (EGFR), a common event in primary GBMs. After a pilot study that found a correlation between this small cell phenotype and EGFR amplification, we selected 9 pure small cell GBMs (SCGBM) and 12 non-SCGBMs to be studied for EGFR amplification by fluorescence in situ hybridization (FISH). In this set of 21 cases, 8 of 9 SCGBMs and 5 of 12 non-SCGBMs were amplified for EGFR. We then correlated the EGFR status of 79 GBMs unselected for their histological features from a set that had been previously characterized in regard to EGFR amplification. Fourteen of 21 (67%) exclusively small cell neoplasms, 8 of 25 (32%) GBMs with both small cell and non-small cell areas, and 3 of 33 (9%) non-small cell GBMs were amplified for EGFR (p = 0.0004 with an exact test). We conclude that EGFR amplification is associated with a small cell phenotype in GBMs and that SCGBMs are an important component of "primary" GBMs.

Original languageEnglish (US)
Pages (from-to)1099-1104
Number of pages6
JournalJournal of Neuropathology and Experimental Neurology
Volume60
Issue number11
DOIs
StatePublished - Jan 1 2001

Fingerprint

Glioblastoma
Epidermal Growth Factor Receptor
Phenotype
Fluorescence In Situ Hybridization

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Neurology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

Burger, Peter C. ; Pearl, Dennis Keith ; Aldape, Kenneth ; Yates, Allan J. ; Scheithauer, Bernd W. ; Passe, Sandra M. ; Jenkins, Robert B. ; James, C. David. / Small cell architecture - A histological equivalent of EGFR amplification in glioblastoma multiforme?. In: Journal of Neuropathology and Experimental Neurology. 2001 ; Vol. 60, No. 11. pp. 1099-1104.
@article{f9e88a41cccc491799310824d1bc8bec,
title = "Small cell architecture - A histological equivalent of EGFR amplification in glioblastoma multiforme?",
abstract = "Although there is much written about the molecular definitions of {"}primary{"} glioblastomas (GBM), there is little known about the histological features of this predominant subtype. We hypothesized that the {"}small cell architecture{"} would represent a histological feature of most primary GBMs. This was tested by comparing the presence of the small cell phenotype with the presence or absence of amplification of the epidermal growth factor receptor (EGFR), a common event in primary GBMs. After a pilot study that found a correlation between this small cell phenotype and EGFR amplification, we selected 9 pure small cell GBMs (SCGBM) and 12 non-SCGBMs to be studied for EGFR amplification by fluorescence in situ hybridization (FISH). In this set of 21 cases, 8 of 9 SCGBMs and 5 of 12 non-SCGBMs were amplified for EGFR. We then correlated the EGFR status of 79 GBMs unselected for their histological features from a set that had been previously characterized in regard to EGFR amplification. Fourteen of 21 (67{\%}) exclusively small cell neoplasms, 8 of 25 (32{\%}) GBMs with both small cell and non-small cell areas, and 3 of 33 (9{\%}) non-small cell GBMs were amplified for EGFR (p = 0.0004 with an exact test). We conclude that EGFR amplification is associated with a small cell phenotype in GBMs and that SCGBMs are an important component of {"}primary{"} GBMs.",
author = "Burger, {Peter C.} and Pearl, {Dennis Keith} and Kenneth Aldape and Yates, {Allan J.} and Scheithauer, {Bernd W.} and Passe, {Sandra M.} and Jenkins, {Robert B.} and James, {C. David}",
year = "2001",
month = "1",
day = "1",
doi = "10.1093/jnen/60.11.1099",
language = "English (US)",
volume = "60",
pages = "1099--1104",
journal = "American Journal of Psychotherapy",
issn = "0002-9564",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

Small cell architecture - A histological equivalent of EGFR amplification in glioblastoma multiforme? / Burger, Peter C.; Pearl, Dennis Keith; Aldape, Kenneth; Yates, Allan J.; Scheithauer, Bernd W.; Passe, Sandra M.; Jenkins, Robert B.; James, C. David.

In: Journal of Neuropathology and Experimental Neurology, Vol. 60, No. 11, 01.01.2001, p. 1099-1104.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Small cell architecture - A histological equivalent of EGFR amplification in glioblastoma multiforme?

AU - Burger, Peter C.

AU - Pearl, Dennis Keith

AU - Aldape, Kenneth

AU - Yates, Allan J.

AU - Scheithauer, Bernd W.

AU - Passe, Sandra M.

AU - Jenkins, Robert B.

AU - James, C. David

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Although there is much written about the molecular definitions of "primary" glioblastomas (GBM), there is little known about the histological features of this predominant subtype. We hypothesized that the "small cell architecture" would represent a histological feature of most primary GBMs. This was tested by comparing the presence of the small cell phenotype with the presence or absence of amplification of the epidermal growth factor receptor (EGFR), a common event in primary GBMs. After a pilot study that found a correlation between this small cell phenotype and EGFR amplification, we selected 9 pure small cell GBMs (SCGBM) and 12 non-SCGBMs to be studied for EGFR amplification by fluorescence in situ hybridization (FISH). In this set of 21 cases, 8 of 9 SCGBMs and 5 of 12 non-SCGBMs were amplified for EGFR. We then correlated the EGFR status of 79 GBMs unselected for their histological features from a set that had been previously characterized in regard to EGFR amplification. Fourteen of 21 (67%) exclusively small cell neoplasms, 8 of 25 (32%) GBMs with both small cell and non-small cell areas, and 3 of 33 (9%) non-small cell GBMs were amplified for EGFR (p = 0.0004 with an exact test). We conclude that EGFR amplification is associated with a small cell phenotype in GBMs and that SCGBMs are an important component of "primary" GBMs.

AB - Although there is much written about the molecular definitions of "primary" glioblastomas (GBM), there is little known about the histological features of this predominant subtype. We hypothesized that the "small cell architecture" would represent a histological feature of most primary GBMs. This was tested by comparing the presence of the small cell phenotype with the presence or absence of amplification of the epidermal growth factor receptor (EGFR), a common event in primary GBMs. After a pilot study that found a correlation between this small cell phenotype and EGFR amplification, we selected 9 pure small cell GBMs (SCGBM) and 12 non-SCGBMs to be studied for EGFR amplification by fluorescence in situ hybridization (FISH). In this set of 21 cases, 8 of 9 SCGBMs and 5 of 12 non-SCGBMs were amplified for EGFR. We then correlated the EGFR status of 79 GBMs unselected for their histological features from a set that had been previously characterized in regard to EGFR amplification. Fourteen of 21 (67%) exclusively small cell neoplasms, 8 of 25 (32%) GBMs with both small cell and non-small cell areas, and 3 of 33 (9%) non-small cell GBMs were amplified for EGFR (p = 0.0004 with an exact test). We conclude that EGFR amplification is associated with a small cell phenotype in GBMs and that SCGBMs are an important component of "primary" GBMs.

UR - http://www.scopus.com/inward/record.url?scp=0034764277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034764277&partnerID=8YFLogxK

U2 - 10.1093/jnen/60.11.1099

DO - 10.1093/jnen/60.11.1099

M3 - Article

C2 - 11706939

AN - SCOPUS:0034764277

VL - 60

SP - 1099

EP - 1104

JO - American Journal of Psychotherapy

JF - American Journal of Psychotherapy

SN - 0002-9564

IS - 11

ER -